Adjunctive rifampicin for Staphylococcus aureus bacteraemia (ARREST): a multicentre, randomised, double-blind, placebo-controlled trial

Guy E. Thwaites*, Matthew Scarborough, Alexander Szubert, Emmanuel Nsutebu, Robert Tilley, Julia Greig, Sarah A. Wyllie, Peter Wilson, Cressida Auckland, Janet Cairns, Denise Ward, Pankaj Lal, Achyut Guleri, Neil Jenkins, Julian Sutton, Martin Wiselka, Gonzalez Ruiz Armando, Clive Graham, Paul R. Chadwick, Gavin BarlowN. Claire Gordon, Bernadette Young, Sarah Meisner, Paul McWhinney, David A. Price, David Harvey, Deepa Nayar, Dakshika Jeyaratnam, Tim Planche, Jane Minton, Fleur Hudson, Susan Hopkins, John Williams, M. Estee Török, Martin J. Llewelyn, Jonathan D. Edgeworth, A. Sarah Walker, Matthew Scarborough, Musa Kamfose, Ana de Veciana, Leon Peto, Gemma Pill, Tiphanie Clarke, Laura Watson, Bernadette Young, Dai Griffiths, Ali Vaughn, Luke Anson, Elian Liu, Pauline Lambert, United Kingdom Clinical Infection Research Group (UKCIRG)

*Corresponding author for this work

Research output: Contribution to journalArticleResearchpeer-review

146 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Adjunctive rifampicin for Staphylococcus aureus bacteraemia (ARREST): a multicentre, randomised, double-blind, placebo-controlled trial'. Together they form a unique fingerprint.

Medicine and Dentistry

Nursing and Health Professions

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology